Hemogenyx Pharmaceuticals PLC (HEMO) — Net Asset Quality Index
Hemogenyx Pharmaceuticals PLC (HEMO) has a Net Asset Quality Index of -17.6% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of GBX3.10 Million minus total liabilities of GBX3.65 Million yields net assets of GBX-546.41K. A higher index indicates a stronger, lower-leverage balance sheet. Also explore HEMO total assets for the complete picture of this company's asset base.
Quality Index
Net Assets
Total Assets
Total Liabilities
Hemogenyx Pharmaceuticals PLC Net Asset Quality Index Over Time (2015–2024)
This chart shows how Hemogenyx Pharmaceuticals PLC's Net Asset Quality Index has evolved across 10 annual periods from 2015 to 2024. As of June 2025, the index stands at -17.6%, representing net assets of GBX-546.41K against total assets of GBX3.10 Million GBX. See Hemogenyx Pharmaceuticals PLC short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Hemogenyx Pharmaceuticals PLC (2015–2024)
The table below presents the year-by-year Net Asset Quality Index for Hemogenyx Pharmaceuticals PLC from 2015 to 2024, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Hemogenyx Pharmaceuticals PLC market cap and net worth.
| Year | Quality Index | Net Assets (GBX) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 20.3% | GBX853.49K | GBX4.21 Million | GBX3.36 Million | ▼ -25.3 pp |
| 2023 | 45.5% | GBX2.78 Million | GBX6.11 Million | GBX3.32 Million | ▼ -0.2 pp |
| 2022 | 45.7% | GBX3.24 Million | GBX7.09 Million | GBX3.85 Million | ▼ -50.1 pp |
| 2021 | 95.9% | GBX8.17 Million | GBX8.52 Million | GBX352.84K | ▲ +63.0 pp |
| 2020 | 32.9% | GBX875.68K | GBX2.66 Million | GBX1.79 Million | ▲ +66.1 pp |
| 2019 | -33.2% | GBX-349.04K | GBX1.05 Million | GBX1.40 Million | ▼ -75.0 pp |
| 2018 | 41.7% | GBX959.17K | GBX2.30 Million | GBX1.34 Million | ▼ -47.3 pp |
| 2017 | 89.0% | GBX2.13 Million | GBX2.40 Million | GBX263.69K | ▲ +2.7 pp |
| 2016 | 86.3% | GBX903.71K | GBX1.05 Million | GBX143.69K | ▲ +62.3 pp |
| 2015 | 24.0% | GBX77.82K | GBX324.65K | GBX246.83K | — |